Rottura, M.; Pirrotta, I.; Giorgi, D.A.; Irrera, N.; Arcoraci, V.; Mannino, F.; Campisi, R.; Bivacqua, C.; Patanè, L.; Costantino, G.;
et al. Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease Patients. Biomedicines 2025, 13, 669.
https://doi.org/10.3390/biomedicines13030669
AMA Style
Rottura M, Pirrotta I, Giorgi DA, Irrera N, Arcoraci V, Mannino F, Campisi R, Bivacqua C, Patanè L, Costantino G,
et al. Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease Patients. Biomedicines. 2025; 13(3):669.
https://doi.org/10.3390/biomedicines13030669
Chicago/Turabian Style
Rottura, Michelangelo, Igor Pirrotta, Domenico Antonio Giorgi, Natasha Irrera, Vincenzo Arcoraci, Federica Mannino, Rosario Campisi, Chiara Bivacqua, Laura Patanè, Giuseppe Costantino,
and et al. 2025. "Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease Patients" Biomedicines 13, no. 3: 669.
https://doi.org/10.3390/biomedicines13030669
APA Style
Rottura, M., Pirrotta, I., Giorgi, D. A., Irrera, N., Arcoraci, V., Mannino, F., Campisi, R., Bivacqua, C., Patanè, L., Costantino, G., Pallio, S., Fries, W., Viola, A., & Pallio, G.
(2025). Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease Patients. Biomedicines, 13(3), 669.
https://doi.org/10.3390/biomedicines13030669
